Morag C. E. McFadyen
Department of Pathology
University of Aberdeen
Foresterhill
Aberdeen AB25 2ZD
UK
Name/email consistency: high
- Cytochrome P450 enzymes: novel options for cancer therapeutics. McFadyen, M.C., Melvin, W.T., Murray, G.I. Mol. Cancer Ther. (2004)
- Cytochrome P450 CYP1B1 activity in renal cell carcinoma. McFadyen, M.C., Melvin, W.T., Murray, G.I. Br. J. Cancer (2004)
- Quantitative analysis of the Ah receptor/cytochrome P450 CYP1B1/CYP1A1 signalling pathway. McFadyen, M.C., Rooney, P.H., Melvin, W.T., Murray, G.I. Biochem. Pharmacol. (2003)
- Cytochrome P450 CYP1B1 protein expression: a novel mechanism of anticancer drug resistance. McFadyen, M.C., McLeod, H.L., Jackson, F.C., Melvin, W.T., Doehmer, J., Murray, G.I. Biochem. Pharmacol. (2001)